Howard Jeng Huang MD
Critical Care Medicine, Interstitial Lung Diseases, Lung Transplantation Medicine, Pleural Disease
Chief, Section of Lung Transplantation, Houston Methodist Hospital
Join to View Full Profile
6550 Fannin StSte 1101Houston, TX 77030
Phone+1 713-441-2215
Fax+1 713-791-5043
Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2008
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Texas Southwestern Medical SchoolClass of 2000
Certifications & Licensure
MO State Medical License 2004 - 2026
TX State Medical License 2003 - 2025
American Board of Internal Medicine Critical Care Medicine- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
- Research Fellowship Award International Society for Heart and Lung Transplantation
- Phillip K. Caves Award International Society for Heart and Lung Transplantation
Publications & Presentations
PubMed
- Complement activity and autophagy are dysregulated in the lungs of patients with nonresolvable COVID-19 requiring lung transplantation.Pooja Shivshankar, Stacey L Mueller-Ortiz, Aleksey Y Domozhirov, Weizhen Bi, Scott D Collum
Respiratory Research. 2025-02-27 - Corrigendum to "Donor-derived cell-free DNA is a valuable monitoring tool after single lung transplantation: Multicenter analysis" [JHLT Open, 6 (2024) 100155].Ambalavanan Arunachalam, Fatima Anjum, Justin P Rosenheck, Reinaldo Rampolla, Reda Girgis
JHLT Open. 2025-02-01 - Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation.Hrishikesh S Kulkarni, Laneshia K Tague, Daniel R Calabrese, Fuyi Liao, Zhiyi Liu
Biorxiv. 2024-11-18
Press Mentions
Basal Stem Cell Variant May Be Therapeutic Target in IPF, Study FindsMay 23rd, 2023- Variant Cells Discovered in Lungs of Individuals with Idiopathic Pulmonary Fibrosis, as Per the Analysis by Science NewsMay 18th, 2023
- Odd Cells Found in Lungs of Patients with Idiopathic Pulmonary FibrosisMay 17th, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
